Agilent Buys Computational Biology to Clinch Market for New DNA Microrray Applications | GenomeWeb

Agilent Technologies on Wednesday announced the acquisition of Cambridge, Mass.-based Computational Biology Corporation, and with it, access to intellectual property that will allow it to expand its microarray product line to include new DNA-based commercial applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.